Related Experiment Videos
Sulodexide and the microcirculatory component in microphlebopathies.
Current Medical Research and Opinion
|January 1, 1992
Summary
Oral sulodexide significantly reduced capillary filtration in patients with chronic venous insufficiency. This treatment positively influences capillary permeability, offering a potential therapeutic option.
Area of Science:
- Vascular Medicine
- Pharmacology
Background:
- Chronic venous insufficiency (CVI) is a condition affecting leg circulation.
- Idiopathic varices are a common cause of CVI, leading to microcirculatory disturbances.
Purpose of the Study:
- To evaluate the efficacy of oral sulodexide in treating CVI.
- To assess the impact of sulodexide on microcirculation and capillary permeability.
Main Methods:
- A 45-day, double-blind, placebo-controlled study involving 36 patients (30-50 years old).
- Patients received either oral sulodexide (2 capsules twice daily) or placebo.
- Strain gauge plethysmography was used to measure the coefficient of capillary filtration.
Main Results:
- Sulodexide significantly reduced the coefficient of capillary filtration at 30 and 45 days.
- The placebo group showed an increase in the coefficient of capillary filtration.
- The difference in outcomes between the sulodexide and placebo groups was statistically significant.
Conclusions:
- Oral sulodexide demonstrates a positive effect on capillary permeability in CVI patients.
- Sulodexide may be an effective treatment for improving microcirculation in CVI.
- Further research into sulodexide for venous disorders is warranted.